Sergiu Paşca
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Genetics top 10%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 34
- Acute Myeloid Leukemia Research 23
- Hematopoietic Stem Cell Transplantation 8
- Chronic Myeloid Leukemia Treatments 8
- Genetics 18
- Myeloproliferative Neoplasms: Diagnosis and Treatment 11
- Chronic Lymphocytic Leukemia Research 6
- Co-authors
- Ciprian TomuleasaAncuța JurjBobe PetrushevIoana Berindan‐NeagoeDelia DimaPatric TeodorescuDaniela MateiVlad Moisoiu
- Journals
- Journal of Clinical Medicine (10 papers)Frontiers in Oncology (7 papers)Frontiers in Immunology (2 papers)Blood Advances (2 papers)Journal of Hepatology (2 papers)
- Partner nations
- RomaniaUnited StatesGermany
In The Last Decade
Sergiu Paşca
63 papers receiving 579 citations
Peers
Comparison fields: 5 of 97
- Hematology 166
- Genetics 94
- Cancer Research 118
- Immunology 86
- Pathology and Forensic Medicine 66
Countries citing papers authored by Sergiu Paşca
This map shows the geographic impact of Sergiu Paşca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergiu Paşca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergiu Paşca more than expected).
Fields of papers citing papers by Sergiu Paşca
This network shows the impact of papers produced by Sergiu Paşca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergiu Paşca. The network helps show where Sergiu Paşca may publish in the future.
Co-authors
The 25 scholars most cited alongside Sergiu Paşca, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 10 | |
| 2 | 2024 | 4 | |
| 3 | 2023 | 4 | |
| 4 | 2023 | 9 | |
| 5 | 2022 | 3 | |
| 6 | 2021 | 7 | |
| 7 | 2021 | 4 | |
| 8 | 2021 | 3 | |
| 9 | 2021 | 0 | |
| 10 | 2021 | 2 | |
| 11 | Comparison of peripheral blood stem cell mobilization with filgrastim versus pegfilgrastim in lymphoma patients - single center experience. | 2021 | 0 |
| 12 | 2020 | 1 | |
| 13 | 2020 | 3 | |
| 14 | 2020 | 1 | |
| 15 | 2020 | 3 | |
| 16 | 2020 | 3 | |
| 17 | 2020 | 5 | |
| 18 | 2020 | 8 | |
| 19 | 2019 | 10 | |
| 20 | 2018 | 70 |
About Sergiu Paşca
Sergiu Paşca is a scholar working on Hematology, Genetics, Pathology and Forensic Medicine, General Dentistry and Cancer Research, having authored 68 papers that have together received 591 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (23 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (11 papers), Hematopoietic Stem Cell Transplantation (8 papers), Chronic Myeloid Leukemia Treatments (8 papers), Lymphoma Diagnosis and Treatment (7 papers), Chronic Lymphocytic Leukemia Research (6 papers), Cancer Genomics and Diagnostics (5 papers) and CAR-T cell therapy research (5 papers). The work is most often cited by research in Hematology (166 citations), Genetics (94 citations), Cancer Research (118 citations), Immunology (86 citations) and Pathology and Forensic Medicine (66 citations). Sergiu Paşca has collaborated with scholars based in Romania, United States and Germany. Frequent co-authors include Ciprian Tomuleasa, Ancuța Jurj, Bobe Petrushev, Ioana Berindan‐Neagoe, Delia Dima, Patric Teodorescu, Daniela Matei, Vlad Moisoiu, Lukasz P. Gondek and Lorand Magdo. Their work appears in journals such as Journal of Clinical Medicine, Frontiers in Oncology, Frontiers in Immunology, Blood Advances and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.